← FDA Drug Approvals (Drugs@FDA)
LARIN FE 1.5/30
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2013-08-23
Drug application
- FDA Application #
ANDA091453
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LARIN FE 1.5/30
- Generic name
- NORETHINDRONE ACETATE/ETHINYL ESTRADIOL AND FERROUS FUMARATE
- Active ingredients
- ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
- Dosage form
- TABLET
- Route
- ORAL-28
- Marketing status
- Prescription
- Sponsor
- NOVAST LABS
- Manufacturer
- Northstar Rx LLC
- First approval
- 2013-08-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown